Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA clears IND for clinical trials of siroquine for newly diagnosed GBM

Aug. 23, 2021

New SREBP inhibitors identified at Capulus Therapeutics

Aug. 23, 2021

Sumitomo Dainippon Pharma Oncology patents serine/threonine kinase Nek2 inhibitors

Aug. 23, 2021

LP-184 induces tumor growth inhibition in glioblastoma models

Aug. 20, 2021

Well Marker Bio starts phase I study of WM-S1-030 for solid tumors

Aug. 19, 2021

TT-00420 enters phase I/II trial for advanced solid tumors

Aug. 19, 2021

Phenex Pharmaceuticals presents new AhR antagonists

Aug. 19, 2021

YAP/TEAD expression defines distinct vulnerabilities in binary pan-cancer groups

Aug. 19, 2021

Jiangsu Simcere Pharmaceutical presents BTK and JAK3 inhibitors

Aug. 18, 2021

Sichuan Kelun-Biotech Biopharmaceutical patents TGFR1 inhibitors

Aug. 18, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...